Cargando…
Erythropoietic Protoporphyria-related Hepatopathy Successfully Treated with Phlebotomy
A 27-year-old man bearing an erythropoietic protoporphyria (EPP)-associated ferrochelatase (FECH) mutation was admitted to our hospital for general malaise and marked elevation of the serum levels of hepatobiliary enzymes and bilirubin. Initial treatment with plasma exchange did not reduce the blood...
Autores principales: | Yoshida, Akihiro, Hagiwara, Satoru, Watanabe, Tomohiro, Nishida, Naoshi, Ida, Hiroshi, Sakurai, Toshiharu, Komeda, Yoriaki, Yamao, Kentaro, Takenaka, Mamoru, Enoki, Eisuke, Kimura, Masatomo, Miyake, Masako, Kawada, Akira, Kudo, Masatoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172546/ https://www.ncbi.nlm.nih.gov/pubmed/30175727 http://dx.doi.org/10.2169/internalmedicine.0673-17 |
Ejemplares similares
-
Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyria
por: Hagiwara, Satoru, et al.
Publicado: (2022) -
Erythropoietic protoporphyria
por: Lecha, Mario, et al.
Publicado: (2009) -
Microcytosis in Erythropoietic Protoporphyria
por: Graziadei, Giovanna, et al.
Publicado: (2022) -
How I treat erythropoietic protoporphyria and X-linked protoporphyria
por: Leaf, Rebecca Karp, et al.
Publicado: (2023) -
Usefulness of Ustekinumab for Treating a Case of Myelodysplastic Syndrome-associated Inflammatory Bowel Disease
por: Kono, Masashi, et al.
Publicado: (2019)